9068 Results

Journal Article

Impact of radiation dose to the immune cells in unresectable or stage III non-small cell lung cancer in the durvalumab era

Authors: Neal S. McCall, Hamilton S. McGinnis, James R. Janopaul-Naylor, Aparna H. Kesarwala, Sibo Tian, William A. Stokes, Joseph W. Shelton, Conor E. Steuer, Jennifer W. Carlisle, Ticiana Leal, Suresh S. Ramalingam, Jeffrey D. Bradley, Kristin A. Higgins

Congress Abstract

Artificial Intelligence based planning of HDR prostate brachytherapy: first clinical experience.

Authors:

Danique Barten1, A. Bouter2, N. van Wieringen1, B.R. Pieters1, K.A. Hinnen1, G.H. Westerveld1, S.C. Maree2, M.C. van der Meer1, T. Alderliesten3, P.A.N. Bosman2, Y. Niatsetski4, A. Bel1

1Amsterdam UMC, University of Amsterdam, Radiation Oncology, Amsterdam, The Netherlands; 2Centrum Wiskunde & Informatica, Life Sciences and Health Group, Amsterdam, The Netherlands; 3LUMC, Radiation Oncology, Leiden, The Netherlands; 4Elekta, -, Veenendaal, The Netherlands

Show Affiliations

Congress Abstract

Overcoming radioresistance with the hypoxia-activated prodrug CP-506: a pre-clinical in vivo study

Authors:

Ala Yaromina1, Lidia Koi2, Alex van der Wiel1, Natasja G. Lieuwes1, Jan Theys1, Ludwig Dubois1, Mechthild Krause3, Philippe Lambin1

1Maastricht University, Department of Precision Medicine, The D-Lab and The M-Lab, GROW – School for Oncology and Developmental Biology, Maastricht, The Netherlands; 2OncoRay – National Center for Radiation Research in Oncology and Helmholtz-Zentrum Dresden - Rossendorf, Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Institute of Radiooncology–OncoRay, Dresden, Germany; 3OncoRay – National Center for Radiation Research in Oncology; and Helmholtz-Zentrum Dresden - Rossendorf, Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Institute of Radiooncology–OncoRay; German Cancer Consortium (DKTK), partner site Dresden; German Cancer Research Center, Heidelberg; National Center for Tumor Diseases (NCT), partner site Dresden; German Cancer Consortium (DKTK), core center Heidelberg; German Cancer Research Center (DKFZ), Dresden, Germany

Show Affiliations

Journal Article

RBE-weighted dose in carbon ion therapy for ACC patients: Impact of the RBE model translation on treatment outcomes

Authors: Silvia Molinelli, Maria Bonora, Giuseppe Magro, Silvia Casale, Jon Espen Dale, Piero Fossati, Azusa Hasegawa, Alfredo Mirandola, Sara Ronchi, Stefania Russo, Lorenzo Preda, Francesca Valvo, Roberto Orecchia, Mario Ciocca, Barbara Vischioni

Journal Article

Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience

Authors: Banu Atalar, Mahmut Ozsahin, Jason Call, Aleksandra Napieralska, Serra Kamer, Salvador Villa, Petek Erpolat, Laura Negretti, Yasmin Lassen-Ramshad, Cem Onal, Serap Akyurek, Gamze Ugurluer, Brigitta G. Baumert, Stephanie Servagi-Vernat, Robert C. Miller, Enis Ozyar, Terence T. Sio

Congress Abstract

Volumetric dosimetry for eye plaque brachytherapy using 3D treatment planning software

Authors:

Mohammad Rezaee1, Ellen Huang1, Marc Morcos1, Harry Quon1, Ana Ponce Kiess1, Zelia Correa2, Robert Hobbs1

1Johns Hopkins University, Radiation Oncology and Molecular Radiation Sciences, Baltimore, USA; 2Johns Hopkins University, Wilmer Eye Institute, Baltimore, USA

Show Affiliations

Journal Article

Ultrafast single breath-hold cone-beam CT lung cancer imaging with faster linac gantry rotation

Authors: Anna Arns, Hansjoerg Wertz, Judit Boda-Heggemann, Frank Schneider, Manuel Blessing, Yasser Abo-Madyan, Volker Steil, Frederik Wenz, Jens Fleckenstein

Congress Abstract

Radiotherapy combined to Duox1 inhibition in macrophages enhances their anti-tumor effect

Authors: Meziani|, Lydia(1)*[lydia.meziani@gustaveroussy.fr];
(1)Institut Gustave Roussy, INSERM U1030, Villejuif, France;
Show Affiliations
*:*